Abacavir 50268-0049
Product NDC
50268-0049- Manufacturer
- Avpak
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 10, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA091560
Need to source Abacavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abacavir Sulfate | 300 mg/1 |
Drug Class
Cytochrome P450 1A1 Inhibitors [MoA]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Reverse Transcriptase Inhibitors [MoA]
Packaging Options(1)
20 BLISTER PACK in 1 BOX (50268-049-12) / 1 TABLET in 1 BLISTER PACK (50268-049-11)